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Objective: This prospective, observational study evaluated the safety and efficacy of superficial femoral artery autograft
reconstruction in the treatment of popliteal artery aneurysms in the absence of a suitable saphenous vein.
Methods: From March 1997 to April 2007, data from patients with popliteal artery aneurysms treated by superficial
femoral artery reconstruction were prospectively collected in two centers. The procedure was performed through a medial
approach. The superficial femoral artery was harvested in the upper third of the thigh and used as the conduit for
reconstruction, and the harvested segment was replaced by a polytetrafluoroethylene graft. The patients were observed for
survival, limb salvage, and reconstruction patency. The results were calculated by the Kaplan-Meier method.
Results: During the 10-year study period, 37 popliteal artery aneurysms in 32 patients (all men; median age, 71 years)
were treated by reconstruction using the superficial femoral artery. Indications for surgical treatment were symptomatic
or complicated aneurysms in 11 (30%). Four (11%) of the 37 popliteal artery aneurysms were thrombosed, and 33 (89%)
were patent. At surgery, 35% had a single vessel runoff. Because of acute ischemia, reconstruction was performed as an
emergency procedure in three patients (8%). There were no perioperative deaths, early amputations, or early thrombosis.
The mean follow-up period was 36months (range, 7-103months). Two grafts thrombosed during follow-up. At 3 years,
the primary and secondary patency rates were 86% and 96%, and overall limb salvage was 100%. Follow-up duplex
ultrasonography did not detect any aneurysmal dilatation of the autograft.
Conclusion: Our experience shows that superficial femoral arterial reconstruction is a safe and useful treatment option in
patients with popliteal artery aneurysms who lack suitable saphenous veins. This reconstruction seems to be a good
alternative to prosthetic bypass crossing the knee joint, and our results suggest that this study should be continued.
(J Vasc Surg 2008;48:311-6.)Popliteal artery aneurysms (PAAs) appear to be rela-
tively uncommon in the general population, with an inci-
dence of 0.1% to 2.8%.1 Nevertheless, PAAs are the most
common peripheral artery aneurysms and account for
70% of all peripheral aneurysms.2,3 PAAs may cause seri-
ous ischemic complications, associated with thromboem-
bolization, which often results in limb loss.4 Open surgical
treatment to exclude the aneurysm with a bypass graft or
endoaneurysmorrhaphy and interposition grafting is still
the treatment of choice for most surgeons.1,4
The most important variable in the ultimate outcome
of surgical below knee revascularization is the choice of
conduit, and every effort is made to use the saphenous vein
for optimal results.1,2 Unfortunately, not all patients have
an adequate saphenous vein, particularly those who have
undergone stripping or coronary revascularization or who
present with varicose vein disease or a saphenous vein with
a small diameter. The aim of this prospective, observational
study was to evaluate the safety and efficacy of a superficial
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doi:10.1016/j.jvs.2008.03.058femoral artery (SFA) autograft reconstruction in the treat-
ment of PAA in patients who lack a suitable saphenous vein.
MATERIAL AND METHODS
Patients. From March 1997 to April 2007, data from
patients with PAA treated by SFA reconstruction in the
Department of Vascular Surgery at Saint-Joseph Hospital
and in the Department of Vascular and Thoracic Surgery at
Bichat Hospital were prospectively collected. These data
included demographics, atherosclerotic risk factors, modes
of presentation, anatomic details concerning the PAA and
the lower limb arteries, reasons for an unavailable saphe-
nous vein, surgical details, and perioperative morbidity.
The diagnosis of PAA was made by duplex ultrasonog-
raphy (DUS) or computed tomography (CT) angiography
(CTA) by multiplanar reconstruction and transverse sec-
tion CT scan. Angiography or CTA was the preferred
preoperative imaging modality to study the runoff.
Surgical treatment was indicated when the PAA was
symptomatic or when a asymptomatic PAA displayed mural
thrombus or was 2 cm in diameter. Reconstruction with
the SFA was used after first considering revascularization
with autologous great saphenous veins (upper limb, femo-
ral, and small saphenous veins were not considered). The
superficial and deep venous systems were evaluated by
DUS. Reconstruction with the SFA was only considered if
the artery did not present any stenotic lesions or calcifica-
tions and when its diameter was 10 mm.
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through a standard medial approach, with the patient su-
pine. The arterial procedure began by controlling the prox-
imal and distal necks of the aneurysm and measuring the
length of graft needed for replacement. Next, the SFA was
exposed in the upper third of the thigh through a separate
incision. The autograft was harvested after systemic hepa-
rinization (Fig 1).
Small PAAs were excluded by ligation of the popliteal
artery proximal and distal to the aneurysm. Larger PAAs
were incised longitudinally, and collaterals were oversewn
within the aneurysm or were completely resected after exter-
nal ligation of the collaterals, at the discretion of the surgeon.
After the distal anastomosis was performed, the graft was
tunneled anatomically between the heads of the gastrocne-
mius, and the proximal anastomosis was completed. All anas-
tomoses were end-to-end.
The last step of the procedure included end-to-end
anastomosis of a polytetrafluoroethylene (PTFE) prosthesis
to replace the harvested SFA. Routine arteriography was
not performed after reconstruction. All incisions were
drained and fasciotomy was performed in patients who
presented with severe acute limb ischemia (IIb).5
Postoperativemanagement and follow-up examination.
After discharge, routine late follow-up included a clinical
and DUS examination at 1 month, 6 months, and yearly
thereafter. Patients were routinely prescribed daily low-
dose aspirin (100 mg). For the purposes of this report, the
status of all survivors was updated in November and De-
cember 2007. Patency, limb salvage rate, and survival were
determined with Kaplan-Meier method.
RESULTS
Patients and procedures. During the 10-year study
period, 37 PAAs in 32 patients (all men; mean age, 71
years) were treated using reconstruction with the SFA.
During the same period, 195 patients (101 at Saint-Joseph
Fig 1. Operative view shows the harvested autograft (the separate
incision in the upper third of the thigh is not seen).Hospital and 94 at Bichat Hospital) underwent vascularreconstruction for PAAs, and a prosthetic graft was used in
24. No patients were treated with an endovascular stent
graft.
The baseline characteristics of the patients are reported
in Table I. Arteriosclerosis was the underlying cause of the
PAA in all cases. A bilateral PAA was present in 20 patients
(62%), and 11 (34%) had an aortoiliac aneurysm.
In five patients (15%), the great saphenous veins were
not available because they had already been used in other
revascularizations (coronary and contralateral limb) or had
been stripped. In 24 patients (75%), the saphenous vein was
present but was not used because of varicosity, a diameter
10 mm or 3.5 mm, or qualitative abnormalities (post-
phlebitic sclerosis, thick wall, vicarious flow). Patients with
suspected small-diameter veins on DUS always underwent
additional surgical exploration. In three recent patients
(Saint-JosephHospital), the SFAwas chosen electively over
the great saphenous vein for treatment of a small aneurysm.
Anatomic variables related to the size of the aneurysm,
tibial outflow vessels, and indications for operative treat-
ment are summarized in Table II. The mean transverse
diameter of the aneurysm was 26 mm (range, 16-55 mm).
Four of the 37 PAAs (11%) were thrombosed, and 33
(89%) were patent. Approximately one-third of patients
had a single-vessel runoff at the time of surgery. Indications
for surgical treatment were symptomatic or complicated
PAAs in 11 (30%). The reconstruction was an emergency
procedure in three patients because of acute ischemia and
was a planned procedure in 34 (92%).
The PAAs were completely resected in 17 patients
(46%), excluded by ligation in five (13%), and incised
longitudinally in 15 (41%). The mean length of the SFA
autograft was 11.2 cm (range, 7-19 cm). No endarterec-
Table I. Clinical characteristics of the 32 patients
Clinical characteristics Valuea
Age, years 71  10.98 (44-92)
Sex
Male 32 (100)
Female 0 (0)
Cigarette smoking 13 (41)
Hypertension 21 (66)
Dyslipidemia 11 (34)
Coronary artery disease 9 (28)
Cerebrovascular eventb 1 (3)
Obesity 1 (3)
Diabetes mellitus 5 (16)
AAAc 11 (34)
Bilateral PAAd 20 (62)
AAA, Abdominal aortic aneurysm; PAA, popliteal artery aneurysm;
SD, Standard deviation.
aContinuous data are presented as mean  standard deviation (range), and
categoric data as number (%).
bDefined as a transient ischemic attack or stroke, or prior carotid endarter-
ectomy.
cAortic diameter3 cm or history of abdominal aortic aneurysm treatment.
dContralateral popliteal artery 15 mm or contralateral popliteal aneurysm
treatment.tomy was performed. Proximal replacement of the au-
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7 mm in 13 patients, 8 mm in 21, and 10 mm in three.
Additional procedures included outflow thrombectomy in
one patient, with local fibrinolysis of the tibial arteries
during the procedure and fasciotomy. The mean duration
of the procedure was 220  31 minutes.
Early outcome (<3 months). There were no periop-
erative deaths, no early amputations, and no early thrombosis
in this series. On postoperative day 5, DUS demonstrated a
stenotic lesion at the junction of the popliteal-anterior tibial
artery in one patient, probably caused by distal clamping.
This patient underwent reoperation and angioplasty with a
venous patch, and the reconstruction was still patent after
36 months.
Two patients had hematomas that required surgical
interventions, with uneventful recovery. One hematoma
was at the site of the SFA harvesting and the other at the site
of the PAA repair. Five patients had minor complications:
hematoma in 2 (treated conservatively), congestive heart
failure in 1, urinary tract infection in 1, and homolateral
thrombophlebitis in 1 that prolonged the duration of hos-
pitalization. Mean duration of hospitalization was 8  2.6
days.
Late outcome. All patients were available for follow-
up (mean, 36 months; range, 7-103 months). Six patients
died during late follow-up in postoperative months 3, 19, 48,
51, and 103. Causes of death were not related to treatment
and includedmyocardial infarction in four, lung cancer in one,
and infectious pneumonia in one. The cumulative survival rate
was 93% at 1 year and 89% at 3 years. No late amputations
were required, leading to an overall limb salvage rate of 100%
Table II. Surgical indications and anatomy of the 37
revascularized limbs
Variable Valuea
Median diameter, mm 26  10.1 (16-55)
Outflow vessels, No.b
1 13c
2 12
3 12
Asymptomatic 26 (70)
20 mm 21
20 mm  thrombus 5
Symptomatic 11 (30)
Acute ischemia 3
Grade IIa 2
Grade IIb 1
Critical limb ischemia 4
Claudication 3
Blue toe syndrome 0
Rupture 0
Compression 1
aContinuous data are presented as mean  standard deviation (range), and
categoric data as number (%).
bOutflow was characterized as the number of tibial vessels intact from origin
to ankle.
cOne patient with grade IIb acute ischemia demonstrated no tibial vessels on
preoperative arteriography; after thrombectomy, one outflow tibial vessel
was obtained.at 3 years.Two autografts and the PTFE graft thrombosed during
follow-up at 14 and 47 months. The patient whose grafts
occluded at 14 months did not undergo surgery because of
poor runoff and absence of critical limb ischemia (severe
claudication). The second patient underwent successful
thrombectomy of both the PTFE and SFA autografts at 47
months associated with angioplasty and stenting of the
distal anastomosis PTFE-SFA, and the reconstruction was
still patent after 7 months. The 3-year primary and second-
ary patency rates were 86% and 96% (Fig 2). Follow-up
DUS did not detect any aneurysmal dilatation of the au-
tograft. Fig 3 shows the results of reconstruction with the
SFA at 6 months.
DISCUSSION
To prevent limb loss, rupture, and morbidity engen-
dered by thromboembolic complications, repair of a PAA is
recommended in symptomatic patients and in asymptom-
atic patients when aneurysms are 2 cm or contain mural
thrombosis.1,6 This has traditionally been accomplished
with elective open surgical repair of PAAs and has yielded
5-year secondary patency rates of 60% to 80%.7-10 Themost
important factors affecting patency and limb salvage in-
clude the number of patent tibial outflow vessels, urgency
of the repair, and conduit choice.
Numerous reports have documented the superiority of
autologous saphenous vein grafts compared with prosthetic
material in the choice of the graft, with 5-year patency rates
of 77% to 95% and 29% to 69%, respectively.10-13 Recently,
Ravn et al4 reported results in 571 patients (717 legs) from
the Swedish Vascular Surgery registry who were primarily
operated on for PAAs.4 A 1-year primary patency of 90%
was obtained with venous bypass and 72% with prosthetic
bypass in patients operated on with a medial approach.
Furthermore, they demonstrated that the use of a pros-
thetic graft was an independent factor associated with the
long-term amputation rate.
The great saphenous vein may be unavailable for many
Fig 2. Primary (squares) and secondary (circles) patency rates
were calculated according to life-table analysis. Error bars repre-
sent standard error of the mean.reasons, including previous harvesting, stripping, varicose
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saphenous vein for treating a PAA can be estimated by
calculating the great saphenous vein/prosthesis ratio, ac-
cording to published reports. Nevertheless, this ratio could
be biased because some groups consider availability of the
great saphenous vein to be a determining criterion for
surgical treatment of asymptomatic aneurysms. Further-
more, the unavailability of this vein has been a factor
recently for choosing the endovascular technique rather
than surgery, so patients may have been excluded from
some surgical studies. In 1994 Varga et al14 reported a
ratio of 77% in a 5-year multicenter and prospective
study including 200 reconstructions, which seems to be
a realistic estimate. This estimate is similar to the findings
of Kropman et al,15 who reported a ratio of 73% in both
groups in a multicenter surgical study comparing the
medial with the posterior approach. In our two-center
studies, the ratio was 70%.
We embarked on a SFA artery autograft reconstruction
program because:
● We were dissatisfied with the results of reconstruction
with PTFE (5-year patency rate of 38%, Saint-Joseph
Hospital; 3-year patency rate of 52%, Bichat Hospital,
unpublished data collected in 1995).
● Our experience with the femoral vein for PAA repair
before this study (Saint-Joseph Hospital) was disap-
pointing. Dilatation and mural thrombosis of these
conduits occurred, necessitating additional surgery
(unpublished data collected in 1997).
● We were reluctant to place a stent graft crossing the
knee because of all the potential inherent problems
ePTFE
Autogra
Fig 3. Angiography demonstrates a patent reconstruc
polytetrafluoroethylene (ePTFE) and (Middle and Rig
anastomoses.associated with movement of the popliteal artery.● The SFA has been shown to be a material of choice for
renal arteries and supra-aortic vessels reconstruction,
especially in young patients with complex reconstruc-
tion or Takayasu disease and in patients presenting
with infection or previous radiation.16-18
Our long-term results of 37 SFA autograft reconstruc-
tions for PAAs in patients lacking suitable saphenous veins
are very encouraging, suggesting that this technique is a
safe and useful option. Although the number of cases
reported is limited, to our knowledge, this is the largest
series dealing with this technique described in the litera-
ture. There were no perioperative deaths or severe compli-
cations in this series, and we achieved a 100% limb salvage
rate and 96% secondary patency at 3 years. Furthermore, no
aneurysmal deterioration of the femoral autograft occurred
during a mean follow-up of 36 months.
Reix et al19 recently reported the first significant series
of PAAs treated with femoral artery autografts, in which 18
aneurysms were treated in 12 patients, and 100% limb
salvage and primary assisted patency was achieved at 2
years. No aneurysmal deterioration of the autograft was
detected during a mean follow-up of 22 months. The main
difference between the technique used by Reix et al19 and
our own is that in six cases a composite grafting technique
was performed. An end-to-end anastomosis was performed
between the harvested SFA and the PTFE graft, and this
composite graft was then placed between the proximal
unharvested SFA and the popliteal artery below the aneu-
rysm. They performed this technique when the autograft
was too short or the SFA above the aneurysmwas the site of
occlusive arterial disease. The second difference was that
Autograft
6 months after the procedure with (Left) expanded
utograft. The arrows indicate the level of the differentft
tion
ht) athey did not perform any aneurysm resection. Puppinck et
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autografts in patients lacking suitable saphenous veins, with
good results after 42 months of follow-up.
The main advantages of using this autograft as an
alternative for PAA repair are high reliability when posi-
tioned across the articular midline as well as excellent
congruence for both anastomoses, allowing end-to-end
anastomosis.
Sepsis of the PTFE prosthesis and aneurysmal deterio-
ration of the autograft are the two potential risks of this
technique. We, like Reix et al,19 did not observe any
prosthetic infections. Although infection remains a serious
risk, it may also occur after surgical in situ reconstruction or
with the use of endovascular stent grafts. As in the Reix et
al19 study, we did not detect any aneurysmal deterioration
at a mean follow-up of 22 and 36 months, respectively.
Nevertheless, close surveillance by DUS of these autografts
is obviously needed, and whether longer follow-up will
reveal aneurysmal deterioration of the autograft is also a
concern.
Another inherent problem with this technique is the
development of anastomotic stenosis between the PTFE
and the SFA, which we observed in one patient in our
series.
Endoluminal bypass with a percutaneously delivered
stent graft has been suggested as an alternative for the
treatment of PAAs.21,22 Although stent grafting is feasible,
until recently the results have been clearly less successful
than open reconstruction. In the study by Gerasimidis et
al23 reporting the use of PTFE-lined nitinol stent grafts in
nine patients with a mean follow-up of 14 months, a
primary patency rate of 47% was obtained. Tiellu et al24
reported 23 PAAs with a median diameter of 30 mm
treated with a stent graft. The median follow-up was 15
months, and the overall patency was 74% at 6 and 12
months.
More recently, better results have been reported by
Antonello et al25 in the only prospective randomized trial.
No significant difference in early death, morbidity, or pa-
tency was obtained between surgical and endovascular re-
pair. This study reported 2-year primary patency rates of
100% for open repair and 80% for endovascular repair.
However, very few articles report the long-term results of
endovascular treatment. A PubMed search found only two
studies with 3-year primary patency rates, which were 72%
and 74% in 57 and 30 PAAs treated, respectively.26,27
Endovascular treatment has the advantage of eliminating
the need for open surgery in high-risk patients and limiting
the morbidity of wound complications.
CONCLUSION
Although this study presents a small series of patients
with limited follow-up, superficial femoral arterial recon-
struction in the treatment of patients with popliteal artery
aneurysms who lack a suitable saphenous vein seems to be a
safe and useful option. This reconstruction offers a good
alternative to prosthetic bypass crossing the knee joint, and
our results encourage us to continue with this study.AUTHOR CONTRIBUTIONS
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